INDIANAPOLIS (WISH) — The state of Indiana will receive an estimated $16.5 million as part of a $720 million national opioid settlement, Attorney General Todd Rokita announced Monday.
The settlement involved eight drugmakers that manufactured opioid pills. The defendants are Alvogen; Amneal; Apotex; Hikma; Indivior; Mylan (now part of Viatris); Sun; and Zydus.
“Thousands of Hoosiers have lost their lives as a result of the opioid crisis,” Rokita said in a release Monday. “We can never undo that tragic loss of life, but we can hold accountable those responsible for contributing to the situations culminating in these deaths. That’s what these settlements are all about, and I’m proud of the work of our team.”
All eight drug makers are banned from promoting opioids or opioid products. They cannot manufacture, promote or distribute any product containing over 40 mg of oxycodone per pill and are not allowed to offer discounts, coupons, or rebates for opioid products.
Some of the companies will make payments to states annually, while others will pay their obligation in a single year, Rokita says.
This settlement brings Indiana to approximately $1.1 billion the total value of opioid settlements achieved since Rokita took office in January of 2021.
About The Author
You may also like
-
Indianapolis on pace for one of the most humid summers on record
-
City of Carmel gives updates on construction projects
-
IMPD: Police shooting on west side of Indianapolis, officer and suspect shot
-
Kroger and union workers extend contract while negotiations continue
-
Man who lit IndyGo bus on fire ordered to pay $1.7 million and gets 8 years in prison